深圳遠揚化學技術有限公司
中級會員 | 第10年

15012456311

西格列汀全套雜質

時間:2017/2/28閱讀:2049
分享:

      西格列汀適應癥及前景:磷酸西格列汀片是*個批準用于治療2型糖尿病的DPP-4抑制劑,可抑制β細胞凋亡,促進β細胞新生,增加2型糖尿病患者β細胞數(shù)量,明顯降低患者血糖,并且對磺脲類藥物失效的患者仍有顯著的降糖作用。磷酸西格列汀片主要通過配合運動和飲食控制實現(xiàn)對2型糖尿病患者的血糖控制。

      經(jīng)上市后超過上千萬余張?zhí)幏降臋z驗,西格列汀進一步顯示出強有效的降糖療效和優(yōu)異的安全性,成為降糖藥物中耀眼的新星。西格列汀的巨大成功也獲得了醫(yī)藥科技界同仁的廣泛贊譽,各種獎項接踵而至,其中zui值得一提的是2007年度的“愛迪生獎”和“蓋倫獎”等殊榮。2009 3月21日,中國國家食品藥品監(jiān)督管理局已正式批準其捷諾維(磷酸西格列?。┰谥袊鲜?, 使之成為國內市場上*用于治療2型糖尿病的(DPP-4)抑制劑。

 

      深圳遠揚化學技術有限公司提供西格列汀全套雜質,隨貨提供結構確認圖譜,純度高,穩(wěn)定性好, (詳情請點擊本頁標題下方“進入該公司展臺” 查看我司信息)。

 

Sitagliptin(R)-3-ami-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
Sitagliptin Impurity 1(R)-3-((tert-butoxycarbonyl)amino)-4-(3,4-difluorophenyl)butanoic acid
Sitagliptin Impurity 2(R)-3-((tert-butoxycarbonyl)amino)-4-(2,4-difluorophenyl)butanoic acid
Sitagliptin Impurity 3(R)-3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid
Sitagliptin Impurity 4(S)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid
Sitagliptin Impurity 5(R)-methyl 3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoate
Sitagliptin Impurity 6(R)-methyl 3-amino-4-(2,4,5-trifluorophenyl)butanoate
Sitagliptin Impurity 7(R)-3-amino-4-(3,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one
Sitagliptin Impurity 8(R)-3-amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one
Sitagliptin Impurity 9(R)-3-amino-4-(2,5-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one
Sitagliptin Impurity 10(R)-3-((tert-butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid
Sitagliptin Impurity 11(R)-tert-butyl (4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)carbamate
Sitagliptin Impurity 12(S)-3-ami-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
Sitagliptin Impurity 131-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butane-1,3-dione
Sitagliptin Impurity 14(Z)-3-ami-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one
Sitagliptin Impurity 15(R)-3-amino-4-(2,4,5-trifluorophenyl)butanoic acid
Sitagliptin Impurity 16(E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-2-en-1-one
Sitagliptin Impurity 17(E)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)but-3-en-1-one

會員登錄

×

請輸入賬號

請輸入密碼

=

請輸驗證碼

收藏該商鋪

X
該信息已收藏!
標簽:
保存成功

(空格分隔,最多3個,單個標簽最多10個字符)

常用:

提示

X
您的留言已提交成功!我們將在第一時間回復您~
撥打電話
在線留言